These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

932 related items for PubMed ID: 33955330

  • 1. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
    Yu ZL, Zhu ZM.
    Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
    [Abstract] [Full Text] [Related]

  • 2. Construction of an N6-methyladenosine lncRNA- and immune cell infiltration-related prognostic model in colorectal cancer.
    Yu ZL, Zhu ZM.
    Protoplasma; 2022 Jul; 259(4):1029-1045. PubMed ID: 34734333
    [Abstract] [Full Text] [Related]

  • 3. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z, Zhang X, Chen D, Li Z, Wu X, Wang J, Deng Y.
    Front Immunol; 2021 Jul; 12():806189. PubMed ID: 35095893
    [Abstract] [Full Text] [Related]

  • 4. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L, Xie R, Lu G.
    Biosci Rep; 2021 Jun 25; 41(6):. PubMed ID: 34027555
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive analysis of N6 -methyladenosine-related long non-coding RNAs for prognosis prediction in liver hepatocellular carcinoma.
    Zhu HX, Lu WJ, Zhu WP, Yu S.
    J Clin Lab Anal; 2021 Dec 25; 35(12):e24071. PubMed ID: 34741346
    [Abstract] [Full Text] [Related]

  • 6. N6-Methyladenosine Related Long Non-Coding RNAs and Immune Cell Infiltration in the Tumor Microenvironment of Gastric Cancer.
    Yu ZL, Zhu ZM.
    Biol Proced Online; 2021 Aug 01; 23(1):15. PubMed ID: 34332535
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y, Zhu GQ, Tian D, Zhou CW, Li N, Feng Y, Zeng MS.
    BMC Cancer; 2022 Mar 24; 22(1):316. PubMed ID: 35331183
    [Abstract] [Full Text] [Related]

  • 8. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
    Qiu Y, Wang X, Fan Z, Zhan S, Jiang X, Huang J.
    Immun Inflamm Dis; 2021 Dec 24; 9(4):1596-1612. PubMed ID: 34432955
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer.
    Zhao Z, Yang YB, Li XY, Li XG, Chu XD, Lin ZB, Zhang YR, Guo YG, Ding H, Pan YL, Wang L, Pan JH.
    Dis Markers; 2021 Dec 24; 2021():8686307. PubMed ID: 34745388
    [Abstract] [Full Text] [Related]

  • 10. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K, Wang F, Li K, Peng G, Yang H, Xu H, Xiang Y, Sun H.
    Technol Cancer Res Treat; 2022 Dec 24; 21():15330338221085354. PubMed ID: 35422168
    [Abstract] [Full Text] [Related]

  • 11. M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma.
    Chen B, Yang Z, Lang Z, Tao Q, Zhang R, Zhan Y, Xu X, Zhu K, Zheng J, Yu Z, Yu S.
    BMC Cancer; 2022 Aug 09; 22(1):867. PubMed ID: 35941582
    [Abstract] [Full Text] [Related]

  • 12. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S, Chen W, Wang Y, Zhang Y, Xia R, Shen J, Gong X, Liang Y, Xu J, Tang H, Zhao T, Zhang Y, Chen T, Wang C.
    BMC Cancer; 2022 Jul 01; 22(1):721. PubMed ID: 35778697
    [Abstract] [Full Text] [Related]

  • 13. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T, Wang X, Meng L, Liu X, Wang J, Zhang W, Tian Z, Zhang Y.
    BMC Cancer; 2021 Nov 21; 21(1):1256. PubMed ID: 34802433
    [Abstract] [Full Text] [Related]

  • 14. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.
    Liu Y, Wang T, Fang Z, Kong J, Liu J.
    J Cancer Res Clin Oncol; 2022 Jul 21; 148(7):1613-1626. PubMed ID: 35314871
    [Abstract] [Full Text] [Related]

  • 15. Expression and prognostic signatures of m6A-related lncRNAs in hepatocellular carcinoma.
    Hao K, Li J, Zhang Y, Zhao W, Chen X, Xu J, Tian Y, Li X, Fen J, He X.
    J Cancer Res Clin Oncol; 2023 Jul 21; 149(8):4429-4441. PubMed ID: 36121511
    [Abstract] [Full Text] [Related]

  • 16. The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy.
    Zou R, Liu Y, Qiu S, Lu Y, Chen Y, Yu H, Zhu H, Zhu W, Zhu L, Feng J, Han J.
    Cancer Biomark; 2023 Jul 21; 38(4):551-566. PubMed ID: 38007640
    [Abstract] [Full Text] [Related]

  • 17. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer.
    Huang J, Song J, Li X, Liu S, Huang W, Shen Z, Cheng Y, Kou S, Gao Z, Tian Y, Hu J.
    BMC Med Genomics; 2022 Jul 25; 15(1):164. PubMed ID: 35879790
    [Abstract] [Full Text] [Related]

  • 18. RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance.
    Zhao H, Zhou Q, Shi C, Shao Y, Ni J, Lou J, Wei S.
    Med Sci Monit; 2021 Oct 25; 27():e930994. PubMed ID: 34690344
    [Abstract] [Full Text] [Related]

  • 19. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q, Ren J, Li L, Li S, Xiang K, Shang D.
    Bioengineered; 2021 Dec 25; 12(1):2432-2448. PubMed ID: 34233576
    [Abstract] [Full Text] [Related]

  • 20. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.
    Shi Y, Wang Y, Zhang W, Niu K, Mao X, Feng K, Zhang Y.
    Front Endocrinol (Lausanne); 2023 Dec 25; 14():1153802. PubMed ID: 37469973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.